Phase 3 KEYNOTE-412 trial: Pembrolizumab plus chemoradiation (CRT) vs CRT alone for locally advanced head and neck squamous cell carcinoma (LA-HNSCC)
Titel:
Phase 3 KEYNOTE-412 trial: Pembrolizumab plus chemoradiation (CRT) vs CRT alone for locally advanced head and neck squamous cell carcinoma (LA-HNSCC)
Auteur:
Machiels, J-P Yen, C-J Licitra, L. Rischin, D. Waldron, J. Burtness, B. Gregoire, V. Tao, Y.G. Yorio, J. Aksoy, S. Ikeda, S. Hong, R-L Ge, J.Y. Brown, H. Bidadi, B. Siu, L.